Methods of using (+) doxazosin for the treatment of hypertension

Details Methods of using (+) doxazosin for the treatment of hypertension Methods of using (+) doxazosin for the treatment of hypertension

1994-03-07

1996-04-23

Cintins, Marianne M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 31495

Patent

active

055103529

ABSTRACT:
Methods are disclosed utilizing the optically pure (+) isomer of doxazosin. This compound is a potent drug for the treatment of hypertension while avoiding the concomitant liability of adverse effects associated with the racemic mixture of doxazosin.

REFERENCES:
patent: 4188390 (1980-02-01), Campbell
patent: 5114714 (1992-05-01), Young et al.
patent: 5114715 (1992-05-01), Young et al.
patent: 5212176 (1993-05-01), Kyncl et al.
"Doxazosin--A Review of Its Pharmacodynamic and Pharmacokinetic . . . " Young et al. Drug Evaluation 35 525-541 (1988).
"Optimisation of Chiral Separation of Doxazosin Enantiomers by High-Performance Liquid Chromatography on a Second Generation .alpha..sub.1 -Acid Glycoprotein Column" Ley et al. Recent Advances in Chiral Separations 97-103 (1991).
"A Pharmacodynamic and Pharmacokinetic Assessment of a New .alpha.-Adrenoceptor Antagonist, Doxazosin (UK33274) In Normotensive Subjects" Elliott et al. Br. J. Clin. Pharmac. 13 699-703 (1982).
"Scrip's New Product Review No. 12 Doxazosin" No Author PJB Publications Ltd. 1-17 (1986).
"Mechanisms Contributing to the Arrhythmogenic Influences of Alpha-Adrenergic Stimulation in the Ischemic Heart" Corr et al., Am. J. of Med. 87 19S-25S (1989).
"2,4-Diamino-6,7-dimethoxyquinazolines. 1. 2- 4-(1,4-Benzodioxan-2-ylcarbonyl)piperazin-1-yl! Derivatives as .alpha..sub.1 -Adrenoceptor Antagonists and Antihypertensive Agents" Campbell et al. J. Med. Chem. 30, 49-57 (1987).
"Stereoselectivity in pharmacodynamics and pharmacokinetics" Ariens Schweiz. Med. Wochenschr. 120, 131-134 (1990).
"Racemische therapeutica probleemmiddelen" Ariens Pharm. Weekblad 125(22) 552-554 (1990).
"Racemates Versus Enantiomers in Drug Development": Dogmatism or Pragmatism? Testa et al. Chirality 2 129-133 (1990).
"Racemic therapeutics--ethical and regulatory aspects" Ariens Eur. J. Clin. Pharmacol. 41 89-93 (1991).

Affiliated with

Also associated with

Rating

Methods of using (+) doxazosin for the treatment of hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of using (+) doxazosin for the treatment of hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of using (+) doxazosin for the treatment of hypertension will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2308655